This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Selvita S.a.. Active years: 2013-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Busko-Zdrój, PL (2013)
- Kraków, PL (2017)
Company Filing History:
Years Active: 2013-2017
Title: The Innovative Contributions of Adrian Zarebski
Introduction
Adrian Zarebski is a prominent inventor based in Kraków, Poland, known for his significant contributions to the field of medicinal chemistry. With a focus on developing novel pharmaceutical agents, he holds two patents that underscore his innovative prowess in combating various cancers and diseases.
Latest Patents
Zarebski's latest patents revolve around the creation of substituted tricyclic benzimidazoles that serve as kinase inhibitors. His first patent discloses these compounds, particularly targeting CDK8, which are instrumental in treating diseases associated with this kinase. This includes colorectal and melanoma cancers, as well as other solid and hematological malignancies, autoimmune diseases, and inflammatory conditions.
The second patent further explores compounds and processes for the preparation of pharmaceutical compositions that modulate serine/threonine and tyrosine kinases, highlighting novel small-molecule compounds with superior kinase inhibitory activity. These advancements hold promise for treating various cancers, especially leukemias and solid tumors, marking Zarebski's contributions as vital in the medical field.
Career Highlights
Adrian Zarebski currently works at Selvita S.A., a research-driven biopharmaceutical company dedicated to the development of innovative drugs. His work in this dynamic environment allows him to collaborate with leading professionals in the industry, working towards groundbreaking solutions for treating serious health conditions.
Collaborations
Zarebski collaborates closely with renowned colleagues, including Krzysztof Brzózka and Wojciech Czardybon. These partnerships enhance the research and development efforts within Selvita S.A., fostering a collaborative spirit that drives innovation and efficacy in their projects.
Conclusion
Adrian Zarebski stands as a remarkable figure in the world of inventions, with his patents paving the way for advancements in cancer treatment and beyond. His dedication to innovation and collaboration showcases the importance of research in developing effective therapeutic agents, making him a noteworthy inventor in the contemporary landscape of medicinal chemistry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile